从早期临床评估来看,阿尔茨海默病的预测速度迅速下降
Lourdes Alvarez-Sanchez1,2, Mar Pereto1, Lorena Garcia-Valles1
1Alzheimer Disease Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
Current neuropharmacology
|October 30, 2024
概括
预测阿尔茨海默病 (AD) 的进展是具有挑战性的. 一个使用三项认知测试的模型显示,在两年内识别患有快速衰退风险的患者时,其准确度最高 (AUC 0.79).
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 老年学是一门学科.
背景情况:
- 阿尔茨海默病 (AD) 的进展是高度可变的,使患者的预后复杂化.
- 由于AD的轻度认知障碍 (MCI) 为预测疾病轨迹带来了诊断挑战.
- 这项研究侧重于因AD而患有MCI的个体和阳性脑脊液 (CSF) 生物标志物.
研究的目的:
- 开发和评估阿尔茨海默病快速进展的预测模型.
- 为了确定哪些神经心理测试最好地预测因AD而导致MCI患者的快速衰退.
- 评估个别认知领域及其综合得分对预后的有用性.
主要方法:
- 一项为期2年的纵向观察性研究,涉及52名因AD而患有MCI的患者和积极的CSF生物标志物.
- 评估临床痴呆症,认知和延迟记忆的神经心理测试在基线 (T1) 和2年随访 (T2) 时进行.
- 使用单个测试分数和所有三个测试的总和创建了进展模型,以预测快速衰退 (定义为Z分数差异<1.5).
主要成果:
- 基于整体认知状态的模型显示出良好的预测性能 (AUC 0.74,83.3%的灵敏度,70.2%的特异性).
- 仅使用临床痴呆或延迟记忆的模型显示预测能力有限.
- 包含所有三项测试总和的模型实现了最高的AUC (0.79),具有高特异性 (未提供) 和中度灵敏性 (63.6%).
结论:
- 开发的进展模型为临床医生和患者提供了关于AD衰退的宝贵见解.
- 对多个认知领域的综合评估似乎比单个措施更有效地预测AD的快速进展.
- 这些模型可以帮助个性化预后和阿尔茨海默病的临床管理策略.
相关概念视频
01:26Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
01:22Alzheimer's Disease: Treatment
171
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
171
01:30Dementia
108
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
108
01:30Cognitive Development During Adulthood
72
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
72